Tanc2-mediated mTOR inhibition balances mTORC1/2 signaling in the developing mouse brain and human neurons

被引:0
|
作者
Sun-Gyun Kim
Suho Lee
Yangsik Kim
Jieun Park
Doyeon Woo
Dayeon Kim
Yan Li
Wangyong Shin
Hyunjeong Kang
Chaehyun Yook
Minji Lee
Kyungdeok Kim
Junyeop Daniel Roh
Jeseung Ryu
Hwajin Jung
Seung Min Um
Esther Yang
Hyun Kim
Jinju Han
Won Do Heo
Eunjoon Kim
机构
[1] Institute for Basic Science (IBS),Center for Synaptic Brain Dysfunctions
[2] Korea Advanced Institute for Science and Technology (KAIST),Graduate School of Medical Science and Engineering
[3] KAIST,Department of Biological Sciences
[4] Institute for Basic Science (IBS),Center for Cognition and Sociality
[5] Korea University,Department of Anatomy and Division of Brain Korea 21, Biomedical Science, College of Medicine
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
mTOR signaling, involving mTORC1 and mTORC2 complexes, critically regulates neural development and is implicated in various brain disorders. However, we do not fully understand all of the upstream signaling components that can regulate mTOR signaling, especially in neurons. Here, we show a direct, regulated inhibition of mTOR by Tanc2, an adaptor/scaffolding protein with strong neurodevelopmental and psychiatric implications. While Tanc2-null mice show embryonic lethality, Tanc2-haploinsufficient mice survive but display mTORC1/2 hyperactivity accompanying synaptic and behavioral deficits reversed by mTOR-inhibiting rapamycin. Tanc2 interacts with and inhibits mTOR, which is suppressed by mTOR-activating serum or ketamine, a fast-acting antidepressant. Tanc2 and Deptor, also known to inhibit mTORC1/2 minimally affecting neurodevelopment, distinctly inhibit mTOR in early- and late-stage neurons. Lastly, Tanc2 inhibits mTORC1/2 in human neural progenitor cells and neurons. In summary, our findings show that Tanc2 is a mTORC1/2 inhibitor affecting neurodevelopment.
引用
收藏
相关论文
共 50 条
  • [1] Tanc2-mediated mTOR inhibition balances mTORC1/2 signaling in the developing mouse brain and human neurons
    Kim, Sun-Gyun
    Lee, Suho
    Kim, Yangsik
    Park, Jieun
    Woo, Doyeon
    Kim, Dayeon
    Li, Yan
    Shin, Wangyong
    Kang, Hyunjeong
    Yook, Chaehyun
    Lee, Minji
    Kim, Kyungdeok
    Roh, Junyeop Daniel
    Ryu, Jeseung
    Jung, Hwajin
    Um, Seung Min
    Yang, Esther
    Kim, Hyun
    Han, Jinju
    Heo, Won Do
    Kim, Eunjoon
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [2] Author Correction: Tanc2-mediated mTOR inhibition balances mTORC1/2 signaling in the developing mouse brain and human neurons
    Sun-Gyun Kim
    Suho Lee
    Yangsik Kim
    Jieun Park
    Doyeon Woo
    Dayeon Kim
    Yan Li
    Wangyong Shin
    Hyunjeong Kang
    Chaehyun Yook
    Minji Lee
    Kyungdeok Kim
    Junyeop Daniel Roh
    Jeseung Ryu
    Hwajin Jung
    Seung Min Um
    Esther Yang
    Hyun Kim
    Jinju Han
    Won Do Heo
    Eunjoon Kim
    Nature Communications, 13
  • [3] Tanc2-mediated mTOR inhibition balances mTORC1/2 signaling in the developing mouse brain and human neurons (vol 12, 2695, 2021)
    Kim, Sun-Gyun
    Lee, Suho
    Kim, Yangsik
    Park, Jieun
    Woo, Doyeon
    Kim, Dayeon
    Li, Yan
    Shin, Wangyong
    Kang, Hyunjeong
    Yook, Chaehyun
    Lee, Minji
    Kim, Kyungdeok
    Roh, Junyeop Daniel
    Ryu, Jeseung
    Jung, Hwajin
    Um, Seung Min
    Yang, Esther
    Kim, Hyun
    Han, Jinju
    Heo, Won Do
    Kim, Eunjoon
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [4] Selective inhibition of mTORC1/2 or PI3K/mTORC1/2 signaling does not prevent or modify epilepsy in the intrahippocampal kainate mouse model
    Gericke, Birthe
    Brandt, Claudia
    Theilmann, Wiebke
    Welzel, Lisa
    Schidlitzki, Alina
    Twele, Friederike
    Kaczmarek, Edith
    Anjum, Muneeb
    Hillmann, Petra
    Loescher, Wolfgang
    NEUROPHARMACOLOGY, 2020, 162
  • [5] Disentangling the signaling pathways of mTOR complexes, mTORC1 and mTORC2, as a therapeutic target in glioblastoma
    Jhanwar-Uniyal, Meena
    Dominguez, Jose F.
    Mohan, Avinash L.
    Tobias, Michael E.
    Gandhi, Chirag D.
    ADVANCES IN BIOLOGICAL REGULATION, 2022, 83
  • [6] mTORC1/mTORC2 SIGNALING IN PILOCYTIC ASTROCYTOMA
    Hutt, Marianne
    Karajannis, Matthias A.
    Shah, Smit
    Eberhart, Charles G.
    Raabe, Eric
    Rodriguez, Fausto J.
    NEURO-ONCOLOGY, 2013, 15 : 48 - 48
  • [7] Rapid turnover of the mTOR complex 1 (mTORC1) repressor REDD1 and activation of mTORC1 signaling following inhibition of protein synthesis
    Kimball, Scot R.
    Do, A. N. Dang
    Kutzler, Lydia
    Cavener, Douglas R.
    Jefferson, Leonard S.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (06) : 3465 - 3475
  • [8] Evidence for Increased mTORC1 and mTORC2 Signaling in Human Thoracic Aortic Aneurysm
    Jbeli, Aiham H.
    Hagler, Michael A.
    Kunkala, Meghana
    Roos, Carolyn M.
    Sundt, Thoralf M.
    Miller, Jordan D.
    CIRCULATION, 2013, 128 (22)
  • [9] Emergence of mTOR mutation as an acquired resistance mechanism to AKT inhibition, and subsequent response to mTORC1/2 inhibition
    Niamh Coleman
    Vivek Subbiah
    Shubham Pant
    Keyur Patel
    Sinchita Roy-Chowdhuri
    Sireesha Yedururi
    Amber Johnson
    Timothy A. Yap
    Jordi Rodon
    Kenna Shaw
    Funda Meric-Bernstam
    npj Precision Oncology, 5
  • [10] Emergence of mTOR mutation as an acquired resistance mechanism to AKT inhibition, and subsequent response to mTORC1/2 inhibition
    Coleman, Niamh
    Subbiah, Vivek
    Pant, Shubham
    Patel, Keyur
    Roy-Chowdhuri, Sinchita
    Yedururi, Sireesha
    Johnson, Amber
    Yap, Timothy A.
    Rodon, Jordi
    Shaw, Kenna
    Meric-Bernstam, Funda
    NPJ PRECISION ONCOLOGY, 2021, 5 (01)